KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Inovio Pharmaceuticals (INO) over the last 11 years, with Q3 2025 value amounting to $669226.0.

  • Inovio Pharmaceuticals' Treasury Shares rose 27964.02% to $669226.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $669226.0, marking a year-over-year increase of 27964.02%. This contributed to the annual value of $337911.0 for FY2024, which is 2296.88% up from last year.
  • As of Q3 2025, Inovio Pharmaceuticals' Treasury Shares stood at $669226.0, which was up 27964.02% from $673462.0 recorded in Q2 2025.
  • Over the past 5 years, Inovio Pharmaceuticals' Treasury Shares peaked at $3.5 million during Q2 2023, and registered a low of $176279.0 during Q3 2024.
  • For the 5-year period, Inovio Pharmaceuticals' Treasury Shares averaged around $1.6 million, with its median value being $2.0 million (2023).
  • As far as peak fluctuations go, Inovio Pharmaceuticals' Treasury Shares plummeted by 9467.44% in 2024, and later surged by 27964.02% in 2025.
  • Inovio Pharmaceuticals' Treasury Shares (Quarter) stood at $2.4 million in 2021, then tumbled by 91.3% to $212964.0 in 2022, then rose by 29.03% to $274794.0 in 2023, then increased by 22.97% to $337911.0 in 2024, then skyrocketed by 98.05% to $669226.0 in 2025.
  • Its last three reported values are $669226.0 in Q3 2025, $673462.0 for Q2 2025, and $464887.0 during Q1 2025.